Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drugs for Treatment of Latent Tuberculosis Infection Objective 4: Identify Biomarkers for Clinical Trials of Drugs Active Against Latent TB

NCT00293228 is registered in ClinicalTrials.gov with Instituto Nacional de Salud Publica, Mexico as lead sponsor.

NCT NCT00293228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00293228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drugs for Treatment of Latent Tuberculosis Infection Objective 4: Identify Biomarkers for Clinical Trials of Drugs Active Against Latent TB
Lead sponsor
Instituto Nacional de Salud Publica, Mexico
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2007
Completion date
June 30, 2009
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis